Jana Matejova

Dr. Jana Matejova

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
MRMaria Rynikova
Maria Rynikova
PAPetra Adamkova
Petra Adamkova
PHPetra Hradicka
Petra Hradicka
JŠJana Štofilová
Jana Štofilová
DHDenisa Harvanova
Denisa Harvanova
Vlasta DemečkováVlasta Demečková
Vlasta Demečková
Two main types of macrophages (Mφ) include inflammatory (M1) and anti-inflammatory (M2) macrophages. These cells can be obtained in vitro by polarization of monocytic cell lines using various stimuli. Since there is currently no consensus on the best method for the acquisition of reliable M1 and M2 macrophages from the THP-1 cell line, we decided to compare three different polarization protocols at the transcriptomic level. Whole transcriptomes of Mφ polarized according to the chosen protocols were analyzed using RNA-seq. Differential expression of genes and functional enrichment for gene ontology terms were assessed. Compared with other protocols, M1 macrophages polarized using PMA (61.3 ng/mL) and IFN-γ along with LPS had the highest expression of M1-associated regulatory genes and genes for M1 cytokines and chemokines. According to the GO enrichment analysis, genes involved in defensive and inflammatory processes were differentially expressed in these Mφ. However, all three chosen protocols which use Vit D3, IL-13/IL-4, and IL-4, respectively, failed to promote the polarization of macrophages with a reliable M2 phenotype. Therefore, optimization or development of a new M2 polarization protocol is needed to achieve macrophages with a reliable anti-inflammatory phenotype.

Verified
Journal Article
Open access
PDF file
JJJana Janockova
Jana Janockova
JMJana Matejova
Jana Matejova
MMMarko Morávek
Marko Morávek
LHLucia Homolova
Lucia Homolova
LSLucia Slovinská
Lucia Slovinská
JRJan Rosocha
Jan Rosocha
Mesenchymal stem cells (MSCs) are of great interest to scientists due to their application in cell therapy of many diseases, as well as regenerative medicine and tissue engineering. Recently, there has been growing evidence surrounding the research based on extracellular vesicles (EVs), especially small EVs (sEVs)/exosomes derived from MSCs. EVs/exosomes can be secreted by almost all cell types and various types of EVs show multiple functions. In addition, MSCs-derived exosomes have similar characteristics and biological activities to MSCs and their therapeutic applications are considered as a safe strategy in cell-free therapy. The aim of this study was the characterization of MSCs isolated from the chorion (CHo-MSCs) of human full-term placenta, as well as the isolation and analysis of small EVs obtained from these cells. Accordingly, in this study, the ability of small EVs’ uptake is indicated by synovial fibroblasts, osteoblasts and periosteum-derived MSCs. Improvement in the understanding of the structure, characteristics, mechanism of action and potential application of MSCs-derived small EVs can provide new insight into improved therapeutic strategies.

Verified
Journal Article
Open access
PDF file
DHDenisa Harvanova
Denisa Harvanova
JMJana Matejova
Jana Matejova
LSLucia Slovinská
Lucia Slovinská
MLMarek Lacko
Marek Lacko
SGSlavomira Gulova
Slavomira Gulova
JRJan Rosocha
Jan Rosocha
There is a lack of in vitro models able to plausibly represent the inflammation microenvironment of knee osteoarthritis (OA). We analyzed the molecules released from OA tissues (synovial membrane, cartilage, infrapatellar fat pad) and investigated whether the stimulation of human synovial fibroblasts (SFs), with synthetic cytokines (IL-1β and TNF-α or IFN-γ) or conditioned media (CM) from OA tissues, influence the SFs’ response, in the sense of pro-inflammatory cytokines, chemokines, growth factors, and degradative enzymes modulation. Human SFs were obtained from OA synovial membranes. SFs and their CM were analyzed for biomarkers, proliferation rate, protein profile and gene expression, before and after stimulation. Real-time PCR and multiplex assays quantified OA-related gene expression and biomolecule production. Unlike other activators, CM from OA synovial membrane (CM-SM), significantly up-regulated all genes of interest (IL-6, IL-8, MMP-1, MMP-3, RANTES, MCP-1, TSG-6, YKL-40) in SFs. Multiplex immunoassay analysis showed that levels of OA-related cytokines (IL-6, IL-8, MCP 1, IL-1Ra), chemokine (RANTES) and growth factor (VEGF), produced by CM-SM stimulated SFs, increased significantly compared to non-stimulated SFs. Molecules released from the SM from OA patients induces OA-like changes in vitro, in specific OA synovial populations (SFs). These findings promote the use and establish a compelling in vitro model that simulates the versatility and complexity of the OA disease. This model, in the future, will allow us to study new cell therapies or test drugs by reducing or avoiding animal models.

27 January 2023 in Life
Verified
Journal Article
Open access
PDF file
MMMarko Morávek
Marko Morávek
JMJana Matejova
Jana Matejova
TSTimea Spakova
Timea Spakova
Osteoarthritis (OA) is the most common degenerative disease of the connective tissue of the human musculoskeletal system. Despite its widespread prevalence, there are many limitations in its diagnosis and treatment. OA diagnosis currently relies on the presence of clinical symptoms, sometimes accompanied by changes in joint X-rays or MRIs. Biomarkers help not only to diagnose early disease progression but also to understand the process of OA in many ways. In this article, we briefly summarize information on articular joints and joint tissues, the pathogenesis of OA and review the literature about biomarkers in the field of OA, specifically inflammatory cytokines/chemokines, proteins, miRNA, and metabolic biomarkers found in the blood, synovial fluid and in extracellular vesicles.

Verified
Journal Article
Open access
PDF file
LSLucia Slovinská
Lucia Slovinská
DHDenisa Harvanova
Denisa Harvanova
JJJana Janockova
Jana Janockova
JMJana Matejova
Jana Matejova
PCPeter Cibur
Peter Cibur
JRJan Rosocha
Jan Rosocha
At present, there is no effective way to treat the consequences of spinal cord injury (SCI). SCI leads to the death of neural and glial cells and widespread neuroinflammation with persisting for several weeks after the injury. Mesenchymal stem cells (MSCs) therapy is one of the most promising approaches in the treatment of this injury. The aim of this study was to characterize the expression profile of multiple cytokines, chemokines, growth factors, and so-called neuromarkers in the serum of an SCI patient treated with autologous bone marrow-derived MSCs (BM-MSCs). SCI resulted in a significant increase in the levels of neuromarkers and proteins involved in the inflammatory process. BM-MSCs administration resulted in significant changes in the levels of neuromarkers (S100, GFAP, and pNF-H) as well as changes in the expression of proteins and growth factors involved in the inflammatory response following SCI in the serum of a patient with traumatic SCI. Our preliminary results encouraged that BM-MSCs with their neuroprotective and immunomodulatory effects could affect the repair process after injury.

29 October 2026 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
LSLucia Slovinská
Lucia Slovinská
JMJana Matejova
Jana Matejova
TSTimea Spakova
Timea Spakova
ZVZuzana Vaczy
Zuzana Vaczy
PCPeter Cibur
Peter Cibur
DHDenisa Harvanova
Denisa Harvanova
Introduction: Mesenchymal Stem Cell (MSC) therapy is a promising strategy for modulating post-traumatic inflammation after Spinal Cord Injury (SCI), yet clinical responses vary widely. This case report introduces a unique, longitudinal biomarker-driven approach to track systemic molecular shifts after cell therapy. It adds to the scientific literature by establishing the MSC Response Index (MSCRI) to quantify how intervention timing alters the subacute and chronic neuroinflammatory landscape. Case Presentation: Two patients with traumatic SCI underwent autologous bone marrow-derived MSC (BM-MSC) transplantation at different time points post-injury (Day 46 vs. Day 73). Circulating cytokines, chemokines, growth factors (including IL-10, IL-1Ra, IL-8, MCP-1, VEGF), and neuromarkers (S100, GFAP, pNF-H) were longitudinally monitored in serum and cerebrospinal fluid. Regarding clinical outcomes, both patients tolerated the transplantation well, achieved systemic stabilization, and were discharged to external rehabilitation facilities. Patient 1 (treated on Day 46) exhibited a robust, sustained early anti-inflammatory response with upregulation of IL-10/IL-1Ra and suppression of pro-inflammatory chemokines. Conversely, Patient 2 (treated on Day 73) showed a limited early response and a subsequent shift toward a pro-inflammatory profile at 6 months. Conclusion: Our findings primarily indicate that the therapeutic window shapes the immunomodulatory potential of BM-MSCs in SCI. Administration during the subacute phase allows for effective, sustained anti-inflammatory shifts, whereas early chronic intervention yields limited molecular effects. Furthermore, the proposed MSCRI provides a simple framework for quantifying inflammatory balance and supporting patient stratification, even when long-term physical rehabilitation occurs externally.